Orally Assimilable Or Injectable Composition Patents (Class 424/643)
  • Patent number: 6855341
    Abstract: Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating lesionous symptoms of a viral infection involving applying an effective amount of the anti-viral composition to the lesions.
    Type: Grant
    Filed: November 4, 2002
    Date of Patent: February 15, 2005
    Inventor: Jeffrey B. Smith
  • Patent number: 6844012
    Abstract: The invention concerns the use of at least a molecule containing selenium, in an amount corresponding to a daily dose of about 2 to 40 mg, even 80 mg of atomic selenium equivalent, on its own or combined with other synergetic molecules for controlling oxidative stress and excessive inflammatory reaction: zinc, vitamin E, vitamin C, iron binder, glutathione precursor, copper and/or copper input binder, for preparing a medicine for treating severe systemic inflammatory response syndrome, in particular any acute infectious condition endangering the patient's life whether of bacterial, parasitic, fungal or viral origin, and any condition corresponding to a severe onset of inflammatory pathology bringing about an exacerbation of cytokine secretion. The invention is applicable in human and veterinary medicine.
    Type: Grant
    Filed: August 30, 1999
    Date of Patent: January 18, 2005
    Inventors: Xavier Forceville, Dominique Vitoux
  • Publication number: 20040265396
    Abstract: This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or wound healing composition alone. In one embodiment, the wound healing composition comprises (a) zinc oxide; (b) calcium channel blocker, and (c) fat-soluble vitamins admixed with antibacterial and antifungal agents. The therapeutic antibacterial/antifungal-wound healing compositions may be utilized in a wide variety of pharmaceutical products and administered orally or topically.
    Type: Application
    Filed: September 30, 2003
    Publication date: December 30, 2004
    Inventor: Mickey L. Peshoff
  • Patent number: 6833362
    Abstract: A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or “pseudo” enzymes for the oxidation. Additives include the oxidant Nicotinamide Adenine Dinucleotide and a variety of other additives such as transition metal ions and complexes thereof which favor the oxidation reaction. The compositions described can act as a sobriety inducer and/or as an effective palliative for the unpleasant effects of overuse of ethanol.
    Type: Grant
    Filed: June 7, 2001
    Date of Patent: December 21, 2004
    Inventors: Ward Beryl Bowen, Jr., Daniel Salman Daniel
  • Publication number: 20040253320
    Abstract: An easily absorbed and well tolerated proportional nutritional supplementation composition and method to be used in patients suffering from deficiency states due to bowel disease that may include malabsorption and inflammatory bowel disease. It is this unique proportional formulation of antacid, calcium, vitamins, minerals and simethicone in lactose free, sorbitol free, gluten free and hypo allergen solution that is the novel invention. This novel invention allows for nutrients to be readily absorbed with little or no side effects that may be experienced when taking conventional supplements. The supplementation contains amounts of vitamins and minerals that are commonly deficient in these states including magnesium, chromium, increased iron, increased folic acid, calcium and fat soluble vitamins.
    Type: Application
    Filed: June 12, 2004
    Publication date: December 16, 2004
    Applicant: Medical Futures Inc.
    Inventor: Pardeep Nijhawan
  • Patent number: 6831103
    Abstract: The present invention relates to a composition for suppressing or ameliorating a symptom accompanying diminished homeostasis, comprising theanine; and a mineral composition comprising theanine and a mineral. According to the present invention, there can be provided a composition for suppressing or ameliorating the above symptoms; and a mineral composition having a reduced peculiar metal taste, of which administration is made easily.
    Type: Grant
    Filed: September 5, 2000
    Date of Patent: December 14, 2004
    Assignee: Taiyo Kagaku Co., Ltd.
    Inventors: Tomoko Ueda, Yukiko Nagato, Yukiko Tanaka, Tsutomu Okubo, Kanari Kobayashi, Nobuyuki Aoi, Seiji Shu, Lekh Raj Juneja
  • Patent number: 6814983
    Abstract: The present invention relates to compositions comprising various vitamins and minerals and methods for using these compositions for nutritional supplementation in, for example, pregnant or lactating subjects.
    Type: Grant
    Filed: December 10, 2002
    Date of Patent: November 9, 2004
    Assignee: Everett Laboratories, Inc.
    Inventors: John A. Giordano, Charles Balzer
  • Publication number: 20040213857
    Abstract: The invention relates to pharmaceutical or dietary unit dosage form, which can be swallowed easily, consisting essentially of vitamins, minerals and trace elements recommended for consumption by pregnant women, lactating women or women of childbearing potential that are attempting to become pregnant, DHA and a pharmaceutically or dietetically suitable carrier.
    Type: Application
    Filed: April 15, 2004
    Publication date: October 28, 2004
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Fabio Soldati, Lara Ambrosetti-Giudici
  • Publication number: 20040170702
    Abstract: A method of treating disorders marked by a loss of pigmentation, comprising the step of administering vitamin B12, copper, folic acid, and vitamin C to a patient suffering from a loss of pigmentation. Additionally, an effective amount of both pantothenic acid and zinc may be administered to said patient. Cutaneous repigmentation can be accelerated by the optional addition of exposure to sunlight or ultraviolet light.
    Type: Application
    Filed: February 23, 2004
    Publication date: September 2, 2004
    Inventor: Audrey VanStockum
  • Patent number: 6776979
    Abstract: An oral compound of water; glycerin; a cranberry source; methylsulfonylmethane; melaleuca alternifolia oil; hydroxyethylcellulose; and a surfactant, in proper combination for use by injecting the compound around a person's gum line followed by its use in a dental tray over a person's teeth and gums for a specified period of time. The next phase to the overall treatment regimen is a daily health care regimen involving: a systemic immune defense compound having colostrum beta 1,3 Glucans; fructo-oligosaccharides; amla fruit 4:1; inositol hexaphosphate; selected minerals; selected enzymes; selected probiotics; and methylsulfonylmethane; an antimicrobial compound having sodium bicarbonate, silicone dioxide, and a cranberry source; and an oral probiotic compound having selected probiotics; vitamin C; and colostrum.
    Type: Grant
    Filed: December 30, 2002
    Date of Patent: August 17, 2004
    Inventors: Marvin B. Frager, R. Douglas Gaynor, John R. Taylor
  • Patent number: 6774111
    Abstract: The two carbohydrate mixture of this invention utilizes a source of fructose in combination with at least one readily digestible glucose polymer source. The addition of the fructose significantly decreases the glycemic response when compared to the digestible glucose polymer alone. Additional components may be added to the simple two component carbohydrate mixture to form a carbohydrate system suitable for incorporation into an enteral nutritional. This carbohydrate system optionally incorporates nonabsorbent carbohydrates, dietary fiber and indigestible oligosaccharides. The present invention is also directed to an enteral nutritional which incorporates the two component carbohydrate mixture and less than 37% of calories from fat. Additionally, the invention is directed to a method of delivering nutrients to a person with diabetes by feeding the enteral nutritional.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: August 10, 2004
    Assignee: Abbott Laboratories
    Inventors: Bryan W. Wolf, Bradley A. Zinker, Keith A. Garleb, Joseph E. Walton
  • Patent number: 6770663
    Abstract: Provided is a method of treating or ameliorating a number of indications in an animal, including a human, comprising administering an effective amount of a compound of the formula I or IA, wherein J is oxygen, sulfur, or N—Rd.
    Type: Grant
    Filed: May 19, 2003
    Date of Patent: August 3, 2004
    Assignee: Alteon, Inc.
    Inventors: Dilip Wagle, Martin Gall, Stanley C. Bell, Edmond J. LaVoie
  • Publication number: 20040142045
    Abstract: A nutritional supplement formulation for the enhancement of blood sugar regulation, prevention and treatment of insulin resistance, prevention and treatment of dysinsulinemia, prevention and treatment of Syndrome X, and reduction of diabetic complications is disclosed. The formulation combines herbs, minerals and vitamins known to reduce insulin resistance with herbs, minerals and vitamins known to reduce blood sugar levels.
    Type: Application
    Filed: January 21, 2003
    Publication date: July 22, 2004
    Inventors: Dennis H. Harris, Robert C. Martin
  • Patent number: 6764692
    Abstract: A method of treating laminitis in a horse is disclosed, comprising administering to the horse a naturally chelated trace mineral composition; promoting healthy skin, hair and hoof tissue. A method of reducing dietary intake is also disclosed, comprising administering to a horse in need thereof, effective amounts of a naturally chelated trace mineral composition. A method of preparing the chelated trace mineral composition from ocean seabed rock is further disclosed, as well as the chelated trace mineral composition.
    Type: Grant
    Filed: August 27, 2002
    Date of Patent: July 20, 2004
    Inventor: Carlos Cortelezzi
  • Publication number: 20040131700
    Abstract: Implantable medical devices using zinc, and methods therefore, provide one or more advantageous effects to a tissue. In one embodiment, at least one zinc-containing component is coupled with a stent via one or more zinc chelators to enhance resistance of the stent to plaque formation and in-stent restenosis. Elastin production may also be enhanced by devices coupled with zinc. Enhanced elastin production may be used, for example, to treat a blood vessel in location at or near an aneurysm. In some embodiments, both elastin production and plaque resistance are enhanced. For example, zinc may be applied via a gel or other carrier substance to a venous graft for enhancing elastin and resisting plaque formation. Implantable devices coupled with zinc may provide improved results of medical and surgical procedures involving implantable devices, thus reducing the need for repeat procedures.
    Type: Application
    Filed: October 22, 2003
    Publication date: July 8, 2004
    Applicant: Essentia Biosystems, Inc.
    Inventors: Pamela Cifra, Michael D. Dake, Christopher Elkins, Jacob M. Waugh
  • Publication number: 20040131643
    Abstract: The invention provides the use of a physiologically tolerable zinc compound for the manufacture of a medicament for use in a method of treatment of an animal to generate a mucosal immune response therein to an antigen, which method comprises administering to said animal a said physiologically tolerable zinc compound and a said antigen whereby to generate said response, preferably by bringing said zinc compound and said antigen into contact with a mucosal surface in said animal.
    Type: Application
    Filed: February 27, 2004
    Publication date: July 8, 2004
    Inventors: Harleen Grewal, Halvor Sommerfelt
  • Patent number: 6756063
    Abstract: Methods and compositions for altering the viability of cells, particularly cancers in animals and humans are disclosed. The compositions of the present invention are formed from a set of components comprising one or more of the following: a dithiocarbonyl, preferably dithiocarbamate, compound; a divalent metal ion; a modulator of cellular glutathione levels; and an inhibitor of the phosphorylation of choline. The compositions described herein induce a relatively selective and rapid effect on the viability of cancer cells by inducing a mixture of apoptotic and necrotic cell death, with the dominant pathway being apoptosis. Particularly preferred active compositions comprise all four components, although combinations of fewer components can be fully effective in certain tumors.
    Type: Grant
    Filed: May 24, 2001
    Date of Patent: June 29, 2004
    Assignee: Zoltan Laboratories, LLC
    Inventor: Zoltan Kiss
  • Publication number: 20040121024
    Abstract: The present invention involves a composition for oral ingestion that contains effective amounts of Glucosamine sulfate, Nettle Leaf, Quercetin, curcumin extract/curcuminoids, Selenium, Zinc, Vitamin C (calcium ascorbate) and Grape Seed Extract, as well as other ingredients and healthy filler ingredients. More specifically, this formulated product is a cartilage and joint maintenance and repair formulation. This formulation allows for enhanced function of joints and cartilage to treat and prevent osteoarthritis, rheumatoid arthritis and other joint ailments/diseases.
    Type: Application
    Filed: December 19, 2002
    Publication date: June 24, 2004
    Inventor: Wayne F. Gorsek
  • Publication number: 20040109901
    Abstract: The present invention relates to compositions comprising various vitamins and minerals and methods for using these compositions for nutritional supplementation in, for example, pregnant or lactating subjects.
    Type: Application
    Filed: December 10, 2002
    Publication date: June 10, 2004
    Inventors: John A. Giordano, Charles Balzer
  • Publication number: 20040091430
    Abstract: Aqueous slurries, capable of cleaning the tongue and throat of a patient when used by an individual for personal hygiene or used on another warm-blooded animal, combine finely-divided charcoal, water, and a biocide. Also disclosed are methods for cleaning areas of the tongue and throat in need thereof. The methods use the disclosed aqueous slurries, as well as apparatus, devices, and tools for contacting the areas to be cleaned with the aqueous slurry and for removing unwanted material from the areas cleaned, as well as from the oral cavity, generally. The disclosed methods can be safely practiced for personal oral hygiene, or on another. Further, kits are disclosed that are useful for such cleaning in providing a contained quantity of a disclosed aqueous slurry or contained quantities of the components thereof, as well as apparatus, devices and tools for effectively preparing and using the same for the above purposes.
    Type: Application
    Filed: November 12, 2002
    Publication date: May 13, 2004
    Inventor: Douglas B. Harwood
  • Publication number: 20040086574
    Abstract: The present invention relates to compositions without added iron and methods for prophylactic nutritional supplementation and therapeutic nutritional supplementation. Specifically, the method involves administering to an individual a composition comprising carotenoids, vitamin E, vitamin D, vitamin C, thiamine, riboflavin, niacin, folic acid, pyridoxine, biotin, pantothenic acid, cobalamin, magnesium, manganese, zinc, selenium, chromium, copper, alpha lipoic acid, and lutein, wherein the composition is free of added iron.
    Type: Application
    Filed: October 14, 2003
    Publication date: May 6, 2004
    Inventors: John A. Giordano, Charles Balzer
  • Publication number: 20040086575
    Abstract: Disclosed are anti-viral compositions containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients), and a pharmaceutical carrier. Also disclosed are methods of treating lesionous symptoms of a viral infection involving applying an effective amount of the anti-viral composition to the lesions.
    Type: Application
    Filed: November 4, 2002
    Publication date: May 6, 2004
    Inventor: Jeffrey B. Smith
  • Patent number: 6730329
    Abstract: One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one analgesic) at least one hydrocarbyl containing compound, and water. Another aspect of the invention relates to a method of treating lesionous symptoms of a viral infection involving applying an effective amount of the zinc containing anti-viral composition to the lesions.
    Type: Grant
    Filed: February 26, 2002
    Date of Patent: May 4, 2004
    Inventor: Jeffrey B. Smith
  • Patent number: 6726919
    Abstract: A sterile, injectable homogenized dispersion of micromatrices or microdroplets having a mean diameter from about 50 nm to about 1000 nm comprising about 1% to about 7.5% of propofol, about 1% to about 8% of a propofol-soluble diluent, and about 0.67% to about 5% of a surface stabilizing amphiphilic agent suspended in an aqueous medium containing a synergetic quantity of antimicrobial agent and a tonicity modifying amount of a pharmaceutically acceptable water-soluble hydroxyl-group-containing excipient, wherein the ratio of propofol to diluent is in the range of about 0.25 to about 7.5 while the ratio of propofol to amphiphilic agent is in the range from about 0.4 to about 1.5, and wherein the viscosity of the dispersion is in the range of 1.1 to 8 cps, processes for the formation of the dispersion, and methods of use are disclosed.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: April 27, 2004
    Assignee: RTP Pharma, Inc.
    Inventors: Gary W. Pace, Michael G. Vachon, Awadesh K. Mishra, Robert A. Snow
  • Publication number: 20040071770
    Abstract: A free radical quenching composition is disclosed comprising a liposome containing at least two antioxidants selected from the following group: beta-carotene, vitamin E, vitamin C, glutathione, niacin, and optionally at least one trace metal (Zn, Se, Cr, Cu, Mn). Also disclosed is a method for reducing the undesirable side effects of free radicals in a mammal by administering to a mammal in need of such antioxidants an effective amount of liposomes containing at least two antioxidants.
    Type: Application
    Filed: September 17, 2003
    Publication date: April 15, 2004
    Inventor: Milton G. Smith
  • Publication number: 20040058014
    Abstract: Compositions for improving the fertility of and/or for improving the quality of semen produced by, a male mammal including a reduced folic acid, at least 13 mg zinc, and vitamin B12.
    Type: Application
    Filed: May 15, 2003
    Publication date: March 25, 2004
    Applicant: N.V. NUTRICIA
    Inventors: Regine Patricia Maria Steegers-Theunissen, Robert Johan Joseph Hageman, Arie Nieuwenhuizen
  • Publication number: 20040052863
    Abstract: A nutritional or dietary supplement composition that strengthens and promotes retinal health through the prevention, stabilization, reversal and/or treatment of visual acuity loss by reducing the risk of developing late stage or advanced age-related macular degeneration in persons with early age-related macular degeneration. The nutritional or dietary supplement composition may likewise reduce the risk of vision loss associated with the development of cataracts. The essential ingredients of the nutritional or dietary supplement composition are vitamin C, vitamin E, beta-carotene, zinc and copper. The essential ingredients are preferably provided in a tablet form suitable for oral ingestion. Preferably the composition is taken in the form of one or two tablets taken twice daily.
    Type: Application
    Filed: August 15, 2003
    Publication date: March 18, 2004
    Inventors: Stephen Paul Bartels, Cara Larraine Baustian, George Edwin Bunce, Leon Ellenbogen, Frederick L. Ferris, Jin Kinoshita, James Cecil Smith, David A. Souerwine
  • Patent number: 6682720
    Abstract: An oral product, particularly for anti-tartar use, is provided which includes from about 0.001 to about 20% of beads which include a zinc salt, the zinc salt having an average particle size ranging from about 0.01 to about 5 mm, and a dental base.
    Type: Grant
    Filed: December 27, 2002
    Date of Patent: January 27, 2004
    Assignee: Unilever Home & Personal Care USA, division of Conopco, Inc.
    Inventors: Christine Watson Ryles, David Robert Williams, Alexander George Ziemkiewicz, Jesus Antonio Urbaez
  • Publication number: 20040013743
    Abstract: The present invention relates to dietary supplements containing low doses of phytoestrogens for supplementing the specific phytochemical dietary needs of perimenopausal and menopausal women.
    Type: Application
    Filed: June 23, 2003
    Publication date: January 22, 2004
    Inventor: Sherry D. Jackson
  • Publication number: 20040005305
    Abstract: A nutritional composition is described for prevention or treatment of an immune condition. The composition includes at least vitamin E, vitamin C, vitamin B6, folic acid, vitamin B12, copper, zinc, selenium, fructo-oligosaccharides and/or gum acacia, a probiotic lactic acid bacterium. For example, in an embodiment it comprises per 300 g: 150 IU Vitamin E, 120 mg Vitamin C, 2 mg Vitamin B6, 400 ug Folic acid, 3.8 ug Vitamin B12, 1.5 mg Copper, 15 mg Zinc, 100 ug Selenium, 3 g Fructo-oligosaccharides and/or gum acacia, 10E10 cfu ST11 lactobacillus. Also disclosed are a method for making the nutritional composition, a method for manufacturing a functional food or medicament; and a method of prevention or treatment of an immune condition by administering an effective amount of the composition, functional food or medicament.
    Type: Application
    Filed: May 13, 2003
    Publication date: January 8, 2004
    Inventors: Evelyn Spivey-Krobath, Claude Cavadini, Ferdinand Haschke, Veronique Jaussan, Eduardo Schiffrin
  • Patent number: 6673835
    Abstract: A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.
    Type: Grant
    Filed: September 1, 1999
    Date of Patent: January 6, 2004
    Assignee: Zicam LLC
    Inventors: Charles Hensley, Robert Steven Davidson
  • Patent number: 6669931
    Abstract: A method of treating dental carries and remineralizing lesions includes the steps of directing a stream of oxidizing gas onto a carious lesions for a period of time sufficient to kill microorganisms within the carious lesion; and thereafter applying to the lesion a remineralization formulation.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: December 30, 2003
    Assignee: Curozone Ireland Limited
    Inventors: Edward Lynch, Jurgen Schemmer
  • Publication number: 20030228375
    Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.
    Type: Application
    Filed: April 25, 2002
    Publication date: December 11, 2003
    Applicant: A. Glenn Braswell
    Inventor: Inna Yegorova
  • Publication number: 20030215430
    Abstract: This invention relates to a method and compositions for the treatment and prevention of disorders associated with endothelial dysfunction consisting of anti-inflammatory agents and dietary supplements.
    Type: Application
    Filed: May 14, 2003
    Publication date: November 20, 2003
    Inventor: Edward J. Petrus
  • Patent number: 6642259
    Abstract: The immune system of middle aged and elderly individuals is stimulated with a dietary supplement. The dietary supplement includes Vitamin E, Vitamin B6 and conjugated linoleic acid. The dietary supplement can further include glutathione alone or in combination with Vitamin C, folic acid, zinc, selenium, Vitamin D, copper and Vitamin B12. The dietary supplement is administered to middle aged and elderly individuals in a suitable form for consumption by the individual. Suitable forms of consumption can include a snack bar, tablet, capsule, powder, drink, or dairy products.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: November 4, 2003
    Assignee: Trustees of Tufts College
    Inventors: Simin Nikbin Meydani, Mohsen Meydani
  • Publication number: 20030203043
    Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.
    Type: Application
    Filed: April 25, 2002
    Publication date: October 30, 2003
    Inventor: Inna Yegorova
  • Publication number: 20030203047
    Abstract: This invention provides compositions and methods related to the administration of deer antler, one or more nor-testosterone precursors, and one or more testosterone precursors, to increase testosterone levels, treat sexual dysfunction, improve sexual function, improve energy, enhance feelings of well-being and increase muscle mass in males. This invention also provides for inhibitors of the enzymes aromatase and/or 5-alpha reductase, to support testosterone levels and avoid undesirable metabolites.
    Type: Application
    Filed: April 25, 2002
    Publication date: October 30, 2003
    Applicant: A. Glenn Braswell
    Inventor: Inna Yegorova
  • Publication number: 20030203045
    Abstract: A pharmaceutical mixture and a method of its production of a therapeutic composition for blocking the HIV-1 and HIV-2 virus replication in the CD4+ cells of the human immune system in all stages of that viral infection, and in AIDS for the treatment of HIV in a patient in need of such treatment.
    Type: Application
    Filed: January 29, 2003
    Publication date: October 30, 2003
    Inventor: Boguslaw Jelen
  • Publication number: 20030180276
    Abstract: A novel salt, creatine taurinate, and the compositions containing same (health foods, dietary supplements or (drugs) are disclosed.
    Type: Application
    Filed: October 30, 2002
    Publication date: September 25, 2003
    Inventor: Antonietta Buononato
  • Publication number: 20030157190
    Abstract: Compositions comprising a biologically available and physiologically acceptable zinc salt are administered to horses to increase their fertility and reproduction. These compositions also can be administered to increase horses' athletic performance.
    Type: Application
    Filed: January 22, 2003
    Publication date: August 21, 2003
    Inventor: Gordon L. Woods
  • Publication number: 20030133992
    Abstract: A method for preventing and or reducing the symptoms of insulin resistance and a related syndrome in persons comprises identifying persons having or at risk for having such symptoms, and administering to them an effective amount of a composition comprising niacin-bound chromium that prevents or reduces the symptoms. Compositions incorporating niacin-bound chromium and additional compounds also are disclosed that are particularly effective in synergistically preventing or reducing these symptoms.
    Type: Application
    Filed: October 4, 2002
    Publication date: July 17, 2003
    Inventors: Debasis Bagchi, Harry G. Preuss, Shil C. Kothari
  • Patent number: 6592852
    Abstract: An anti-tartar oral product is provided which includes from about 0.001 to about 20% of beads which include a zinc salt and a gum held in a water matrix, the zinc salt and gum being present in a relative weight ratio from about 10,000:1 to about 10:1, and a dental base.
    Type: Grant
    Filed: April 25, 2002
    Date of Patent: July 15, 2003
    Assignee: Unilever Home & Personal Care USA, division of Conopco, Inc.
    Inventors: Christine Watson Ryles, David Robert Williams, Alexander George Ziemkiewicz, Jesus Antonio Urbaez
  • Patent number: 6592849
    Abstract: A chewing gum composition for controlling malodorous breath when chewed comprising a gum base having present therein a breath freshening amount of a water soluble zinc ion releasing salt and a phosphate salt mixture of alkali metal pyrophosphate and polyphosphate salts at a weight ratio of about 2:1 to 1:3 whereby the presence of the phosphate salt mixture enhances and extends the release of the zinc ion during the period of chewing.
    Type: Grant
    Filed: June 21, 2001
    Date of Patent: July 15, 2003
    Assignee: Colgate Palmolive Company
    Inventors: Richard S. Robinson, Timothy E. Bruce, John P. Curtis, Donna M. Vroom, Bernie P. Blackwell, Poul N&phgr;rgaard Poulsen, Lars Gyldenvang
  • Patent number: 6579541
    Abstract: The invention relates to a method and composition for destroying or inhibiting proliferation of microbes using oxidative fluorinator compounds. Fluoride salts that do not dissociate completely in aqueous solutions, such as tri- or tetravalent transition metal fluorides, inert gas fluorides, or tri- or tetravalent rare earth fluorides, are effective antimicrobial agents even at levels up to about 20 ppm, when used alone or in conjunction with a strong oxidizer.
    Type: Grant
    Filed: March 16, 2001
    Date of Patent: June 17, 2003
    Assignee: Marantech Holding, LLC
    Inventor: Marvin S. Antelman
  • Patent number: 6576634
    Abstract: A composition for improving the fertility of a male, and/or for improving the quality of the semen produced by a male includes at least one source of folic acid, preferably 0.05-8 mg; at least one source of zinc, preferably 5-50 mg; and optionally one or more of vitamin B12, magnesium, betaine, choline, SAM, vitamin B2, and Vitamin B6; and/or optionally one or more carriers, excipients and/or adjuvants.
    Type: Grant
    Filed: July 7, 2000
    Date of Patent: June 10, 2003
    Assignee: N.V. Nutricia
    Inventors: Regine Patricia Maria Steegers-Theunissen, Robert Johan Joseph Hageman, Arie Nieuwenhuizen
  • Publication number: 20030099727
    Abstract: Compositions and methods for reducing cytotoxicity are provided. Compositions and methods for inhibiting angiogenesis are provided. The compositions comprise herbals, natural nutritional supplements, minerals and/or vitamins.
    Type: Application
    Filed: May 6, 2002
    Publication date: May 29, 2003
    Inventors: Yuanjin Tao, Lily C. Yang
  • Patent number: 6565891
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among children.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: May 20, 2003
    Assignee: Tsar Health Private Ltd.
    Inventor: Ranjit Kumar Chandra
  • Patent number: 6562378
    Abstract: A multinutrient nutritional supplement is provided that is designed to be most effective in optimizing health, increasing the immunity and decreasing the instances and severity of infection particularly among adolescents.
    Type: Grant
    Filed: August 16, 2002
    Date of Patent: May 13, 2003
    Assignee: TSAR Health Private Ltd.
    Inventor: Renjit Kumar Chandra
  • Publication number: 20030077333
    Abstract: The present invention is directed to a zinc supplemented ORS and its use in the treatment of diarrhea.
    Type: Application
    Filed: June 4, 2001
    Publication date: April 24, 2003
    Inventors: Kenneth M. Phillips, Amy L. Marchio, Paul F. Pollack
  • Publication number: 20030077336
    Abstract: A nutritional supplement includes flaxseed oil, ginger, sesame, citrus, garlic, tumeric, vitamins and minerals. The nutritional supplement preferably includes about 400 to 800 mg of flaxseed oil, about 50 to 100 mg of ginger, about 50 to 100 mg of sesame, about 50 to 100 mg of citrus, about 50 to 100 of garlic, about 10 to 30 mg of tumeric, about 6 to 10 mg of Vitamin C, about 1 to 5 IU of Vitamin E, about 0.25 to 1 mg of Vitamin B6, about 0.25 to 1 mg of niacin, about 3 to 6 mg of magnesium, and about 0.25 to 1 mg of zinc. The nutritional supplement may be used in a method of treating inflammation by administering to a patient in need thereof an effective dose of the nutritional supplement.
    Type: Application
    Filed: November 6, 2002
    Publication date: April 24, 2003
    Applicant: MAF Group, LLC
    Inventor: Philip B. Maffetone